Skip to main content

Epigenetics Communications is accepting submissions and will publish its first articles soon.

Editorial Policy Regarding Submissions Focusing on Non-coding RNAs or RNA Modifications

Since epigenetic regulation and associated aspects of transcription regulation are wide-spread and complex, Epigenetics Communications aims to focus on those aspects of ncRNA-induced epigenetic regulation that concern changes in chromatin organization. As such manuscripts on non-coding RNAs or RNA modifications are only acceptable for the journal when including: 

  • data on the molecular epigenetic regulation of the expression of non-coding RNA (or its modifying enzymes) or
  • insights on the mechanism of action of the non-coding RNA on the chromatin and/or functioning of the DNA or
  • insights in mitotic stability of the RNA-induced effect

Editorial Policy Regarding Submissions Focusing on In silico research

Manuscripts reporting on straightforward bioinformatic analyses of publicly accessible databases only, cannot be considered for publication in Epigenetics Communications, unless the manuscript presents:

  • new, convincingly-described, scientific insights which will impact the field and/or
  • additional insights into underlying biological mechanisms (“wet-lab” validations) and/or
  • validations of findings in a replication cohort

Editors-in-Chief

Lucia Altucci, Università degli Studi della Campania, Italy
Marianne Rots, University Medical Center Groningen, Netherlands  

Aims and scope

Encompassing the broad spectrum of epigenetics research from basic research to innovations towards therapeutic treatments, Epigenetics Communications is an innovative new, open-access journal devoted to the study of epigenetic principles and mechanisms in basic research settings. In support of open science initiatives, the journal will have a level 4 data policy requiring data be made publically available. The journal is divided into the following sections:

  • Molecular Epigenetics (Histone Modifications; DNA Methylation; DNA Demethylation)
  • Nuclear Organization
  • Mitotic & Meiotic Heritability
  • Epigenetic Drugs
  • Epigenetic Technologies
  • Epigenetic Bioengineering
  • Network Epigenetics
  • Computational Epigenomics
  • Single Cell Epigenetics
  • Epigenetic Toxicology
  • Model Organisms (Vertebrates; Invertebrates; Plants; Unicellular systems)

Epigenetics Communications will support the publication of manuscripts that contribute to a further understanding of epigenetic mechanisms that impact functioning of systems and organisms. Submissions describing clinical applications are referred to the sister journal, Clinical Epigenetics.

This new and innovative journal will also act as a forum to showcase and discuss alternative conclusions/interpretations of well-established epigenetic phenomena based on (re-)analyses of published or new data. As such, we welcome 'systematic studies', be it positive (expected) or negative (non-expected) with respect to its outcome.

In detail, provided that the methodology is consistent and sound, and the research question brings added value to the field, ‘negative results’ studies which might be considered include, but are not limited to, descriptions of:

  • (failed) attempts to reproduce previously published data
  • irreproducible data between two (collaborating) laboratories
  • failed, but technically solid, attempts to prove a scientific hypothesis

Manuscripts which will not be considered include:

  • bioinformatic analyses without a solid statistical approach
  • "stand alone" bioinformatic analyses without experimental proof